Roberto Speck
Roberto Speck
Professor of Infectious Diseases at the University Hospital of Zurich
Verified email at
Cited by
Cited by
Combination antiretroviral therapy and the risk of myocardial infarction
Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group
New England Journal of Medicine 349 (21), 1993-2003, 2003
Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study
S Collins, T Mertenskoetter, E Loeliger, R Tressler, I Weller, N Friis-Møller, ...
Archives of internal medicine 166 (15), 1632-1641, 2006
Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop.
RF Speck, K Wehrly, EJ Platt, RE Atchison, IF Charo, D Kabat, ...
Journal of virology 71 (9), 7136-7139, 1997
Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2−/− γc−/− mice
S Baenziger, R Tussiwand, E Schlaepfer, L Mazzucchelli, ...
Proceedings of the National Academy of Sciences 103 (43), 15951-15956, 2006
Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America
Antiretroviral Therapy Cohort Collaboration
Clinical Infectious Diseases 41 (12), 1772-1782, 2005
Folate receptor-α is a cofactor for cellular entry by Marburg and Ebola viruses
SY Chan, CJ Empig, FJ Welte, RF Speck, A Schmaljohn, JF Kreisberg, ...
Cell 106 (1), 117-126, 2001
Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection
PY Bochud, M Hersberger, P Taffé, M Bochud, CM Stein, SD Rodrigues, ...
Aids 21 (4), 441-446, 2007
Ageing with HIV: medication use and risk for potential drug–drug interactions
C Marzolini, D Back, R Weber, H Furrer, M Cavassini, A Calmy, ...
Journal of antimicrobial chemotherapy 66 (9), 2107-2111, 2011
Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses
SY Chan, RF Speck, MC Ma, MA Goldsmith
Journal of virology 74 (10), 4933-4937, 2000
Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology
S Baenziger, M Heikenwalder, P Johansen, E Schlaepfer, U Hofer, ...
Blood 113 (2), 377-388, 2009
TLR7/8 triggering exerts opposing effects in acute versus latent HIV infection
E Schlaepfer, A Audigé, H Joller, RF Speck
The Journal of Immunology 176 (5), 2888-2895, 2006
Broad-range 16S rRNA gene polymerase chain reaction for diagnosis of culture-negative bacterial infections
SK Rampini, GV Bloemberg, PM Keller, AC Büchler, G Dollenmaier, ...
Clinical Infectious Diseases 53 (12), 1245-1251, 2011
Antigen kinetics determines immune reactivity
P Johansen, T Storni, L Rettig, Z Qiu, A Der-Sarkissian, KA Smith, ...
Proceedings of the National Academy of Sciences 105 (13), 5189-5194, 2008
Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 …
A Cozzi-Lepri, M Noguera-Julian, F Di Giallonardo, R Schuurman, ...
Journal of antimicrobial chemotherapy 70 (3), 930-940, 2015
Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1
OT Keppler, FJ Welte, TA Ngo, PS Chin, KS Patton, CL Tsou, NW Abbey, ...
The Journal of experimental medicine 195 (6), 719-736, 2002
V3 recombinants indicate a central role for CCR5 as a coreceptor in tissue infection by human immunodeficiency virus type 1
SY Chan, RF Speck, C Power, SL Gaffen, B Chesebro, MA Goldsmith
Journal of Virology 73 (3), 2350-2358, 1999
Plasma cell toll‐like receptor (TLR) expression differs from that of B cells, and plasma cell TLR triggering enhances immunoglobulin production
M Dorner, S Brandt, M Tinguely, F Zucol, JP Bourquin, L Zauner, C Berger, ...
Immunology 128 (4), 573-579, 2009
Determinants of HIV-1 broadly neutralizing antibody induction
P Rusert, RD Kouyos, C Kadelka, H Ebner, M Schanz, M Huber, DL Braun, ...
Nature medicine 22 (11), 1260-1267, 2016
Human immunodeficiency virus type 1 coreceptor preferences determine target T-cell depletion and cellular tropism in human lymphoid tissue
JC Grivel, ML Penn, DA Eckstein, B Schramm, RF Speck, NW Abbey, ...
Journal of virology 74 (11), 5347-5351, 2000
Viral entry through CXCR4 is a pathogenic factor and therapeutic target in human immunodeficiency virus type 1 disease
B Schramm, ML Penn, RF Speck, SY Chan, E De Clercq, D Schols, ...
Journal of Virology 74 (1), 184-192, 2000
The system can't perform the operation now. Try again later.
Articles 1–20